De-Escalation Protocol Of HPV Mediated Oropharyngeal Squamous Cell Carcinoma

Conditions:   HPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Clinical Stage;   Oropharynx Cancer Interventions:   Procedure: Transoral robotic surgery;   Drug: Cisplatin - Dose Level 1;   Drug: Cisplatin - Dose Level 2;   Radiation: Dose Level 1;   Radiation: Dose Level 2 Sponsor:   Nebraska Methodist Health System Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials